In this interview with labiotech.eu, Dr David Hallett, Executive Vice President at Evotec, the uniqueness of Induced Pluripotent Stem Cells (iPS Cells), novel developments occurring in iPS Cell research, and the challenges researchers face is discussed.
Download the article below to read the interview.
